Search

Search Constraints

You searched for: Author/Creator Williamson, S.

Search Results

1. 127P Phase I study of fianlimab: A human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced NSCLC. (December 2022)